Wash. Joins Suit Over Novartis Exjade Kickbacks

Law360, Washington (January 27, 2014, 6:03 PM EST) -- The state of Washington on Friday intervened in a False Claims Act whistleblower case against Novartis Pharmaceuticals Corp. for allegedly paying kickbacks to a specialty pharmacy to keep patients on its iron reduction drug Exjade, saying it hopes to recoup the Medicaid funds it lost.

U.S. District Judge Colleen McMahon granted Washington's unopposed motion to intervene in the case two days after it was filed, as the state claimed its Medicaid program lost state funds due to Novartis' kickback scheme.

The qui tam suit was unsealed...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.